Revenue

A student stock competition turns into real-world opportunity, as a Moomoo and W!se partnership awards thousands to NYC schools and their top students.

An InsurTech spin-off is slashing costs and speeding up agent onboarding, setting a new benchmark for a legacy industry resistant to change.

As tax fraud spikes, Allstate unveils an industry-first plan to give victims their stolen refund money upfront, tackling a growing financial nightmare.

Thermon Group's $2.2 billion sale to CECO Environmental faces legal scrutiny, leaving shareholders to question if the offer is fair amid record profits.

With a fresh $40M in funding, Letter AI is challenging sales tech incumbents by moving beyond static playbooks to real-time, deal-specific AI guidance.

A new report on 1,800+ patients reveals a model for obesity care that preserves muscle, sustains weight loss, and may solve the GLP-1 cost crisis.

A global leader in OEM security is recognized for its inCompass platform, which silently protects billions from escalating mobile and encrypted threats.

New AI and data tools in Elite's 3E platform promise to slash reporting times, automate billing, and streamline global compliance for modern law firms.

With a record EU investment, Axelera AI challenges AI's energy crisis with power-efficient edge chips, aiming for global leadership and digital sovereignty.

With a massive Series A, Alveus Therapeutics is advancing novel drugs aiming for more durable and higher-quality weight loss than current blockbusters.

A new GenAI chatbot is replacing frustrating product manuals, earning a top award and signaling a major shift in customer experience for retail.

Dr. Frank Smith joins XenoSTART to lead its preclinical unit, aiming to leverage its vast patient-derived model library to speed up oncology drug development.

Fresh off strong 2025 earnings, AtriCure will detail its growth strategy and innovative cardiac portfolio at a major life sciences conference.

Hyperlink InfoSystem unveils AI agents promising to slash operational costs by up to 90%, signaling a major shift in workforce and business strategy.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

Fort Worth Plastic Surgery's new partnership with a PE-backed group highlights a major industry shift, raising questions about growth, autonomy, and patient care.

The merger, backed by private equity, creates a dominant force in higher education services, aiming to tackle digital transformation and student success.

With 80% of Indian diets lacking protein, the fast-food giant is serving up a science-backed solution. But can a burger truly bridge a national nutrition gap?

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

A new voter tool uses AI to score Texas primary candidates on collaboration over conflict, aiming to reshape how voters choose their representatives.